pharma · Attention Deficit Disorder With Hyperactivity · Hidradenitis suppurativa (HS) · AVTX
Avalo Therapeutics
Avalo Therapeutics trial registry — 19 ClinicalTrials.gov studies with program phase, status, and indication context.
1500 Liberty Ridge Dr, Chesterbrook, Pennsylvania 19087, US HQ
2011 Founded
48 Employees
Public company Type
AVTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1500 Liberty Ridge Dr, Chesterbrook, Pennsylvania 19087, US
- Founded
- 2011
- Employees
- 48
- Programs
- 17
- Drugs
- 2
- Patents
- 10
Avalo Therapeutics clinical trials
Registry index of 19 ClinicalTrials.gov studies linked to Avalo Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Avalo Therapeutics trial registry — 19 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Avalo Therapeutics.
-
Placebo to AVTX-009, AVTX-009 — Phase 2
Clinical update -
AVTX-009 Regimen 1 — Phase 2
Clinical update -
NFC-1 — Phase 3
Clinical update -
AEVI-001 — Phase 2
Clinical update -
AVTX-002 — Phase 2
Clinical update -
CERC-002 — Phase 2
Clinical update -
CERC-301 — Phase 2
Clinical update -
FP01 — Phase 2
Clinical update